Analysts Set Corteva, Inc. (NYSE:CTVA) PT at $88.14

Corteva, Inc. (NYSE:CTVA) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ratings firms that are covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $88.1429.

CTVA has been the subject of several research analyst reports. Wells Fargo & Company upped their price target on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Rothschild & Co Redburn upped their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, Royal Bank Of Canada increased their target price on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th.

Institutional Investors Weigh In On Corteva

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CTVA. Activest Wealth Management lifted its position in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva in the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust purchased a new stake in Corteva in the 4th quarter worth approximately $28,000. Finally, Redmont Wealth Advisors LLC purchased a new stake in Corteva in the 3rd quarter worth approximately $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.7%

Shares of NYSE:CTVA opened at $79.57 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a market cap of $53.22 billion, a PE ratio of 46.81, a price-to-earnings-growth ratio of 2.43 and a beta of 0.59. Corteva has a 52 week low of $60.53 and a 52 week high of $85.63. The firm has a 50 day simple moving average of $81.33 and a 200 day simple moving average of $73.96.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts expect that Corteva will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 42.35%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.